Adverum Biotechnologies Stock Price History

ADVM Stock  USD 6.45  0.29  4.71%   
If you're considering investing in Adverum Stock, it is important to understand the factors that can impact its price. As of today, the current price of Adverum Biotechnologies stands at 6.45, as last reported on the 28th of November, with the highest price reaching 6.46 and the lowest price hitting 6.19 during the day. Adverum Biotechnologies secures Sharpe Ratio (or Efficiency) of -0.0154, which signifies that the company had a -0.0154% return per unit of risk over the last 3 months. Adverum Biotechnologies exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Adverum Biotechnologies' Mean Deviation of 2.66, insignificant risk adjusted performance, and Standard Deviation of 3.53 to double-check the risk estimate we provide.
  
Adverum Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = -0.0154

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsADVM

Estimated Market Risk

 3.53
  actual daily
31
69% of assets are more volatile

Expected Return

 -0.05
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 -0.02
  actual daily
0
Most of other assets perform better
Based on monthly moving average Adverum Biotechnologies is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Adverum Biotechnologies by adding Adverum Biotechnologies to a well-diversified portfolio.

Adverum Biotechnologies Stock Price History Chart

There are several ways to analyze Adverum Stock price data. The simplest method is using a basic Adverum candlestick price chart, which shows Adverum Biotechnologies price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest PriceOctober 18, 20248.48
Lowest PriceNovember 21, 20245.75

Adverum Biotechnologies November 28, 2024 Stock Price Synopsis

Various analyses of Adverum Biotechnologies' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Adverum Stock. It can be used to describe the percentage change in the price of Adverum Biotechnologies from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Adverum Stock.
Adverum Biotechnologies Price Daily Balance Of Power 1.07 
Adverum Biotechnologies Price Rate Of Daily Change 1.05 
Adverum Biotechnologies Price Action Indicator 0.27 

Adverum Biotechnologies November 28, 2024 Stock Price Analysis

When benchmark price declines in a down market, there may be an uptick in Adverum Stock price where buyers come in believing the asset is cheap or selling overdone. The opposite is true when the market is bullish. You can use Adverum Biotechnologies intraday prices and daily technical indicators to check the level of noise trading in Adverum Stock and then apply it to test your longer-term investment strategies against Adverum.

Adverum Stock Price History Data

The price series of Adverum Biotechnologies for the period between Fri, Aug 30, 2024 and Thu, Nov 28, 2024 has a statistical range of 2.73 with a coefficient of variation of 8.54. The prices are distributed with arithmetic mean of 7.27. The median price for the last 90 days is 7.3. The company had 1:10 stock split on 21st of March 2024.
OpenHighLowCloseVolume
11/28/2024
 6.22  6.46  6.19  6.45 
11/27/2024 6.22  6.46  6.19  6.45  292,341 
11/26/2024 6.13  6.20  5.98  6.16  133,219 
11/25/2024 6.13  6.33  6.10  6.15  206,290 
11/22/2024 5.75  6.15  5.69  6.04  452,190 
11/21/2024 6.11  6.16  5.70  5.75  873,726 
11/20/2024 6.26  6.34  6.00  6.17  221,338 
11/19/2024 6.86  6.90  6.14  6.25  623,105 
11/18/2024 7.30  7.73  6.85  6.85  413,032 
11/15/2024 7.29  7.29  6.81  6.86  233,650 
11/14/2024 7.64  7.64  7.23  7.25  204,388 
11/13/2024 7.90  8.05  7.53  7.56  124,399 
11/12/2024 7.79  7.97  7.59  7.89  202,229 
11/11/2024 8.18  8.18  7.75  7.76  147,086 
11/08/2024 7.91  8.06  7.83  8.00  126,243 
11/07/2024 7.98  8.12  7.87  7.90  110,736 
11/06/2024 8.02  8.08  7.76  7.94  187,667 
11/05/2024 7.53  7.77  7.26  7.72  104,786 
11/04/2024 7.49  7.73  7.30  7.54  127,563 
11/01/2024 7.32  7.51  7.17  7.41  175,843 
10/31/2024 7.90  7.90  7.29  7.30  130,288 
10/30/2024 7.74  8.07  7.71  7.88  187,501 
10/29/2024 7.96  8.01  7.62  7.76  171,035 
10/28/2024 8.02  8.20  7.86  7.92  235,538 
10/25/2024 8.21  8.21  7.90  7.98  92,368 
10/24/2024 8.17  8.27  8.03  8.08  97,137 
10/23/2024 8.02  8.27  7.90  8.12  142,661 
10/22/2024 8.28  8.33  8.08  8.14  183,046 
10/21/2024 8.44  8.53  8.18  8.26  211,367 
10/18/2024 8.08  8.56  8.02  8.48  166,708 
10/17/2024 8.20  8.30  7.93  8.08  198,190 
10/16/2024 7.79  8.21  7.77  8.21  242,261 
10/15/2024 7.72  7.86  7.56  7.69  149,985 
10/14/2024 7.65  7.85  7.44  7.73  168,092 
10/11/2024 7.44  7.67  7.40  7.65  134,275 
10/10/2024 7.42  7.47  7.20  7.44  134,502 
10/09/2024 7.56  7.86  7.32  7.52  214,918 
10/08/2024 7.41  7.91  7.41  7.61  126,259 
10/07/2024 7.57  8.14  7.40  7.44  335,636 
10/04/2024 7.41  7.70  7.19  7.53  381,494 
10/03/2024 6.79  7.49  6.71  7.28  191,539 
10/02/2024 6.53  7.03  6.53  6.82  1,014,555 
10/01/2024 6.95  6.99  6.54  6.59  214,405 
09/30/2024 6.90  7.11  6.90  7.02  76,161 
09/27/2024 6.73  7.08  6.66  6.94  108,786 
09/26/2024 6.66  6.77  6.52  6.61  128,769 
09/25/2024 6.95  7.03  6.57  6.59  135,281 
09/24/2024 6.91  7.11  6.87  6.94  289,044 
09/23/2024 7.48  7.48  6.88  6.88  160,640 
09/20/2024 7.42  7.69  7.38  7.49  281,932 
09/19/2024 7.12  7.66  7.12  7.50  231,419 
09/18/2024 7.30  7.42  6.97  6.99  342,887 
09/17/2024 7.30  7.67  7.14  7.30  180,075 
09/16/2024 7.29  7.49  7.16  7.21  176,159 
09/13/2024 7.11  7.38  7.05  7.23  99,834 
09/12/2024 7.05  7.22  6.93  7.05  133,926 
09/11/2024 7.14  7.18  6.90  7.03  105,328 
09/10/2024 7.00  7.20  6.90  7.18  93,586 
09/09/2024 6.78  7.07  6.77  6.96  124,457 
09/06/2024 6.81  6.83  6.54  6.76  101,887 
09/05/2024 6.87  7.00  6.66  6.82  112,941 

About Adverum Biotechnologies Stock history

Adverum Biotechnologies investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Adverum is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Adverum Biotechnologies will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Adverum Biotechnologies stock prices may prove useful in developing a viable investing in Adverum Biotechnologies
Adverum Biotechnologies, Inc., a clinical-stage gene therapy company, develops gene therapy product candidates to treat ocular and rare diseases. Adverum Biotechnologies, Inc. was incorporated in 2006 and is headquartered in Redwood City, California. Adverum Biotechnlgs operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 188 people.

Adverum Biotechnologies Stock Technical Analysis

Adverum Biotechnologies technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Adverum Biotechnologies technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Adverum Biotechnologies trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Did you try this?

Run Bollinger Bands Now

   

Bollinger Bands

Use Bollinger Bands indicator to analyze target price for a given investing horizon
All  Next Launch Module

Adverum Biotechnologies Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Adverum Biotechnologies' price direction in advance. Along with the technical and fundamental analysis of Adverum Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Adverum to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
When determining whether Adverum Biotechnologies is a strong investment it is important to analyze Adverum Biotechnologies' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Adverum Biotechnologies' future performance. For an informed investment choice regarding Adverum Stock, refer to the following important reports:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Adverum Biotechnologies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.
To learn how to invest in Adverum Stock, please use our How to Invest in Adverum Biotechnologies guide.
You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Adverum Biotechnologies. If investors know Adverum will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Adverum Biotechnologies listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Adverum Biotechnologies is measured differently than its book value, which is the value of Adverum that is recorded on the company's balance sheet. Investors also form their own opinion of Adverum Biotechnologies' value that differs from its market value or its book value, called intrinsic value, which is Adverum Biotechnologies' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Adverum Biotechnologies' market value can be influenced by many factors that don't directly affect Adverum Biotechnologies' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Adverum Biotechnologies' value and its price as these two are different measures arrived at by different means. Investors typically determine if Adverum Biotechnologies is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Adverum Biotechnologies' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.